NAUT
NASDAQ
$1.69
Nautilus Biotechnology Inc (NAUT)
Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is headquartered in Seattle, Washington.
Sector:
Healthcare
Industry:
Biotechnology
Target: $4 (+136.69%)
Market Cap
$221M
Free Cash Flow Yield
-23.26%
Beta (5Y)
1.79
Price Chart
Valuation
Market Cap$221M
P/B1.55
Profitability
EBITDA-$56M
EPS-$0.45
Financial Health
Free Cash Flow Yield-23.26%
Growth & Risk
Beta (5Y)1.79
Sharpe Ratio1.26